Department of Public Health and Animal Sciences, Faculty of Veterinary Medicine, University of Bari, Italy.
Res Vet Sci. 2012 Oct;93(2):843-7. doi: 10.1016/j.rvsc.2012.01.005. Epub 2012 Jan 30.
Twenty-four dogs naturally infected by Leishmania spp. were treated with four different protocols using meglumine antimoniate (aNm) and allopurinol in combination or in monotherapy. Aiming to compare the efficacy of the different treatments the reverse to normal of clinico-pathological findings and the disease free interval time (DFIT) were evaluated. Treated dogs were monitored for 1 year and, in absence of relapses, the DFIT was postponed to the last available follow-up. Seven dogs treated with aNm alone showed relapses during the year of observation. In the group of dogs treated with the combination of aNm (50 mg/kg/SC 12 hourly up to clinico-pathological recovery) and allopurinol (15 mg/kg/PO 12 hourly administered for 6months) no relapses were registered in the year of monitoring and the DFIT reached up to 65 months. Our results showed that this combination represents the best choice to treat canine leishmaniosis compared to other protocols.
24 只自然感染利什曼原虫的狗分别采用四种不同的方案进行治疗,方案中联合或单独使用了葡甲胺锑和别嘌呤醇。本研究旨在比较不同治疗方案的疗效,对临床病理发现和无疾病间隔时间(DFIT)进行了反转正常评估。治疗犬接受了为期 1 年的监测,在无复发的情况下,DFIT 被推迟到最后一次可获得的随访。7 只单独使用葡甲胺锑治疗的狗在观察期内复发。在联合使用葡甲胺锑(50mg/kg/SC,每 12 小时 1 次,直至临床病理恢复)和别嘌呤醇(15mg/kg/PO,每 12 小时 1 次,共 6 个月)的治疗组中,在监测的 1 年内未出现复发,DFIT 达到 65 个月。我们的结果表明,与其他方案相比,这种联合方案是治疗犬利什曼病的最佳选择。